Ben Wu

Ben Wu is a seasoned healthcare executive with extensive experience in multiple leadership roles across the pharmaceutical industry. They served as the Head of Rare Disease Business at CANbridge Pharmaceuticals Inc. and as Chief Executive Officer at Citrine Medicine. Previously, Ben held managerial positions at Genzyme Pharmaceuticals, Sanofi Genzyme, and the Janssen Pharmaceutical Companies of Johnson & Johnson, focusing on various aspects of marketing and management. Currently, Ben is a Partner in Healthcare at Agio Capital, leveraging their significant expertise in the field. Ben earned a Bachelor of Pharmacy and a Master of Business Administration from The University of British Columbia.